基于超声的序贯算法整合AI模型用于进展期肝纤维化筛查
本回顾性研究纳入三个医疗机构的慢性肝病或不明原因肝功能异常成人患者,构建包含超声深度学习模型(FIB-Net)的序贯临床算法,以肝活检为参考标准比较其与其他无创检查预测进展期肝纤维化的效能。结果显示,两步法(FIB-4后接FIB-Net)和三步法(FIB-4后接FIB-Net及SWE)较FIB-4或EASL指南分别减少42%和35%的不必要转诊,并提高特异度和阳性预测值。
要点
- FIB-Net以SWE值≥8.7 kPa为训练标签预测进展期肝纤维化,其特异度非劣于SWE(80% vs 82%,非劣效界值5%,P < .001)。
- 两步法(FIB-4后接FIB-Net)较单用FIB-4提高特异度(79% vs 57%)和PPV(44% vs 32%),减少42%不必要转诊。
- 三步法(FIB-4后接FIB-Net及SWE)较EASL指南提高特异度(94% vs 88%)和PPV(73% vs 64%),减少35%不必要转诊。
核心结论
- 序贯算法联合FIB-4与超声深度学习模型,较单用FIB-4或单用DL模型提高了全因进展期肝纤维化的诊断准确性和转诊管理。
研究设计与样本
- 回顾性研究,纳入2014年1月至2022年9月三个医疗机构有慢性肝病病史或不明原因肝功能异常、接受肝脏B型超声的成人患者;训练集3067例(中位年龄42岁,IQR 33-53岁;男性2083例),验证集1599例(中位年龄41岁,IQR 33-51岁;男性1124例),测试集1228例(中位年龄44岁,IQR 33-55岁;男性741例);以肝活检为参考标准。
诊断标准与关键数值
- FIB-Net在超声图像上训练预测SWE值≥8.7 kPa(提示进展期纤维化);FIB-Net与SWE特异度分别为80% vs 82%(非劣效界值5%,P < .001);两步法(FIB-4后接FIB-Net)与FIB-4特异度79% vs 57%、PPV 44% vs 32%;三步法(FIB-4后接FIB-Net及SWE)与EASL指南(FIB-4后接SWE)特异度94% vs 88%、PPV 73% vs 64%。
临床应用与阅片要点
- 在无或有所需肝脏硬度测量条件下,可分别采用两步法(FIB-4后接FIB-Net)或三步法(FIB-4后接FIB-Net及SWE)序贯筛查进展期肝纤维化,以减少不必要转诊。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Noninvasive tests can be used to screen patients with chronic liver disease for advanced liver fibrosis; however, the use of single tests may not be adequate. Purpose To construct sequential clinical algorithms that include a US deep learning (DL) model and compare their ability to predict advanced liver fibrosis with that of other noninvasive tests. Materials and Methods This retrospective study included adult patients with a history of chronic liver disease or unexplained abnormal liver function test results who underwent B-mode US of the liver between January 2014 and September 2022 at three health care facilities. A US-based DL network (FIB-Net) was trained on US images to predict whether the shear-wave elastography (SWE) value was 8.7 kPa or higher, indicative of advanced fibrosis. In the internal and external test sets, a two-step algorithm (Two-step#1) using the Fibrosis-4 Index (FIB-4) followed by FIB-Net and a three-step algorithm (Three-step#1) using FIB-4 followed by FIB-Net and SWE were used to simulate screening scenarios where liver stiffness measurements were not or were available, respectively. Measures of diagnostic accuracy were calculated using liver biopsy as the reference standard and compared between FIB-4, SWE, FIB-Net, and European Association for the Study of the Liver guidelines (ie, FIB-4 followed by SWE), along with sequential algorithms. Results The training, validation, and test data sets included 3067 (median age, 42 years [IQR, 33-53 years]; 2083 male), 1599 (median age, 41 years [IQR, 33-51 years]; 1124 male), and 1228 (median age, 44 years [IQR, 33-55 years]; 741 male) patients, respectively. FIB-Net obtained a noninferior specificity with a margin of 5% (P < .001) compared with SWE (80% vs 82%). The Two-step#1 algorithm showed higher specificity and positive predictive value (PPV) than FIB-4 (specificity, 79% vs 57%; PPV, 44% vs 32%) while reducing unnecessary referrals by 42%. The Three-step#1 algorithm had higher specificity and PPV compared with European Association for the Study of the Liver guidelines (specificity, 94% vs 88%; PPV, 73% vs 64%) while reducing unnecessary referrals by 35%. Conclusion A sequential algorithm combining FIB-4 and a US DL model showed higher diagnostic accuracy and improved referral management for all-cause advanced liver fibrosis compared with FIB-4 or the DL model alone. © RSNA, 2024 Supplemental material is available for this article. See also the editorial by Ghosh in this issue.
引用
- Chen LD, Huang ZR, Yang H, et al. US-based Sequential Algorithm Integrating an AI Model for Advanced Liver Fibrosis Screening. Radiology. 2024. PMID: 38652028. doi:10.1148/radiol.231461
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。